Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
BioMarin Pharmaceutical Inc
SWB:BM8
BioMarin Pharmaceutical Inc
SWB:BM8
Price:
52.86
EUR
1.89%
Market Cap:
€10B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
B
|
BioMarin Pharmaceutical Inc
SWB:BM8
|
US |
|
MERLIN Properties SOCIMI SA
OTC:MRPRF
|
ES |
|
L
|
Levi Strauss & Co
SWB:LV2B
|
US |
|
K
|
Kiatnakin Phatra Bank PCL
SET:KKP
|
TH |
|
A
|
Ad Pepper Media International NV
SWB:APM
|
DE |
|
V
|
ViTrox Corporation Bhd
KLSE:VITROX
|
MY |
Wall St Price Targets
BM8 Price Forecast
Based on 27 analysts
Based on 27 analysts
+49% Upside
from
€52.86
today
BioMarin Pharmaceutical Inc (BM8)’s 12-month stock price forecast through August 2027 has a consensus target of €78.69, implying 49% upside. The forecast is based on price targets from 27 Wall Street analysts.
BM8 Analyst Rating
No ratings yet
No ratings yet
BioMarin Pharmaceutical Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BM8's stock price target?
Price Target
78.69
EUR
78.69
EUR
According to Wall Street analysts, the average 1-year price target for BM8 is 78.69 EUR with a low forecast of 51.95 EUR and a high forecast of 111.61 EUR.
What is the Revenue forecast for BioMarin Pharmaceutical Inc?
Projected CAGR
8%
8%
Over the last 13 years, the compound annual growth rate for Revenue has been 15%. The projected CAGR for the next 8 years is 8%.
What is the Gross Profit forecast for BioMarin Pharmaceutical Inc?
Projected CAGR
8%
8%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 15%. The projected CAGR for the next 8 years is 8%.
What is the Operating Income forecast for BioMarin Pharmaceutical Inc?
Projected CAGR
14%
14%
The compound annual growth rate for Operating Income over the next 8 years is 14%.
What is the Pre-Tax Income forecast for BioMarin Pharmaceutical Inc?
Projected CAGR
48%
48%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 48%.
What is the Net Income forecast for BioMarin Pharmaceutical Inc?
Projected CAGR
24%
24%
The compound annual growth rate for Net Income over the next 8 years is 24%.